WallStreetZenWallStreetZen

NASDAQ: FTH
Faeth Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Faeth Therapeutics earnings were -$195.5M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest FTH earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$16.0M, down 90.6% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, FTH reported annual earnings of -$21.1M, with -30.1% growth.

FTH earnings history

Current Revenue
$0.0
Current Earnings
-$195.5M
Current Profit Margin
0%

FTH Return on Equity

Current Company
-1,012.2%
Current Industry
-13.6%
Current Market
30.9%
FTH's Return on Equity (-1,012.2%)... subscribe to Premium to read more.
High Return on Equity Performance

FTH Return on Assets

Current Company
-175.7%
Current Industry
-10.2%
FTH is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when FTH announces earnings.

FTH Return on Capital Employed

Current Company
-108.79%
Current Industry
-6.7%
FTH's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

FTH vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
FTH-$193.89M-$195.53MN/A-$141.65
TBPH$65.87M$53.81M-96.85%$1.07
WVE-$193.31M-$202.47MN/A-$1.08
AVTX-$100.05M-$100.33MN/A-$4.37
SANA-$193.29M-$211.82MN/A-$0.76
View Top Biotech Stocks

Faeth Therapeutics Earnings Reports & History FAQ

What were Faeth Therapeutics's earnings last quarter?

On FTH's earnings call on Aug 4, 2026, Faeth Therapeutics (NASDAQ: FTH) reported Q2 2026 earnings per share (EPS) of -$2.84, up 27.37% year over year. Total FTH earnings for the quarter were -$16.01 million. In the same quarter last year, Faeth Therapeutics's earnings per share (EPS) was -$3.91.

If you're new to stock investing, here's how to buy Faeth Therapeutics stock.

Is Faeth Therapeutics profitable or losing money?

As of the last Faeth Therapeutics earnings report, Faeth Therapeutics is currently losing money. Faeth Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$195.53 million, a 628.96% increase year over year.

What was FTH's earnings growth in the past year?

As of Faeth Therapeutics's earnings date in Aug 4, 2026, Faeth Therapeutics's earnings has grown year over year. FTH earnings in the past year totalled -$195.53 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.